Novo Nordisk (NVO), the maker of the blockbuster drug Ozempic, is cutting the price of its weight loss drug by more than half ...

Eli Lilly began offering vials of the two lowest doses of Zepbound, which is typically sold in auto-injector pens, in August. Danish drugmaker Novo Nordisk will also offer home delivery of ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's ... VK2735 with an auto-injector could delay ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

which has an easy auto-injector mechanism. “These marketing authorisations constitute significant milestones for Novo Nordisk and the treatment of diabetes. We look forward to making Tresiba and ...

Novo Nordisk said on Wednesday it would begin selling its ... Eli Lilly began offering vials of the two lowest doses of Zepbound, which is typically sold in auto-injector pens, in August. It now sells ...

Following in the steps of its rival Eli Lilly (LLY), Novo Nordisk (NVO), the maker ... syringe instead of the more convenient auto-injector pen that treatment usually comes in.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about Ozempic's and Mounjarno's patent cliffs. The scenarios in which Novo ...

If you assume that Lilly and Novo Nordisk continue to dominate the ... They've started to offer, instead of just the auto injector pens, they've offered the drugs and vials at reduced prices.

Both new doses can be bought for $499 for a month's supply via the company's LillyDirect direct-to-consumer self-pay channel, $150 lower than it charges for the injector pen formulations of those ...